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ABSTRACT 
 
In this study, high resolution reflection-mode (backward-mode) photoacoustic microscopy (PAM) is used to 
noninvasively image progressive extravasation and accumulation of nanoshells within a solid tumor in vivo. This study 
takes advantage of the strong near-infrared absorption of nanoshells, a novel type of optically tunable gold nanoparticles 
that tend to extravasate from leaky tumor vasculatures (i.e., passive targeting) via the “enhanced permeability and 
retention” effect due to their nanoscale size. Tumors were grown in immunocompetent BALB/c mice by subcutaneous 
inoculation of CT26.wt murine colon carcinoma cells. PEGylated nanoshells with a peak optical absorption at ~800 nm 
were intravenously administered. Pre-scans prior to nanoshell injection were taken using a 584-nm laser source to 
highlight blood content and an 800-nm laser source to mark the background limit for nanoshell accumulation. After 
injection, the three-dimensional nanoshell distribution inside the tumor was monitored by PAM for 7 hours. 
Experimental results show that nanoshell accumulation is heterogeneous in tumors: more concentrated within the tumor 
cortex and largely absent from the tumor core. This correlates with others’ observation that drug delivery within tumor 
cores is ineffective because of both high interstitial pressure and tendency to necrosis of tumor cores. Since nanoshells 
have been recently applied to thermal therapy for subcutaneous tumors, we anticipate that PAM will be important to this 
therapeutic technique. 
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1. INTRODUCTION 
 
Contrast-agent-aided optical imaging techniques have high sensitivity and specificity. Pure optical imaging, 
however, faces a major challenge—the overwhelming optical scattering in biological tissue; as a result, its spatial 
resolution significantly decreases with increasing imaging depth. Photoacoustic imaging, a novel hybrid imaging 
modality, which combines the merits of both light and ultrasound, has been applied to measuring the optical properties 
of biological tissues noninvasively1.  It has been shown a promising tool for visualizing tissue structures and functions 
with high optical contrast, good spatial resolution, and satisfactory imaging depth2.  
 
Recently, an in vivo backward-mode confocal photoacoustic microscope (PAM) with dark-field illumination was 
invented by Maslov et al. to image blood vessels in the skin3.  This system offers high lateral resolution (45 µm at the 
focal point) and high axial resolution (~15 µm), and it is capable of imaging optical absorption contrast as deeply as 3 
mm in biological tissue. This PAM system shows potential for applications in dermatology and related cancer research. 
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Our research goal for this study is to develop a nanoparticle-based technique which integrates photoacoustic 
imaging and photothermal therapy for seamless detection and treatment of solid tumors. The nanoparticle we used here 
is gold nanoshell, which trade name is AuroShellTM, provided by Nanospectra Biosciences, Inc. A gold nanoshell is a 
new kind of optically tunable nanoparticle, consisting a silica core surrounded by a thin gold layer. By adjusting the size 
of the nanoparticle core relative to the thickness of the gold shell, gold nanoshells can absorb various wavelengths of 
light4. Recently, gold nanoshells have been applied to photothermal therapy for subcutaneous murine tumors5, and also 
have been used as a contrast agent for in vivo brain images using photoacoustic tomography, in which gold nanoshells 
enhance the image contrast of the cortex vessels in a rat brain6.  
 
In this study, we use gold nanoshells as contrast agents of tumor imaging. The PAM is used to noninvasively image 
progressive extravasation of gold nanoshells from solid tumor vasculature in vivo without any invasive biological 
modification such as a dorsal skin-fold window chamber7. Nanoshells tend to preferentially extravasate and accumulate 
in tumors – a preferential, size dependent accumulation – via the “enhanced permeability and retention” effect due to 
their nanoscale size (i.e., passive targeting)5,8. We anticipate that the integration of PAM into gold-nanoshell based 
photothermal therapy to characterize and monitor the accumulation of gold nanoshells in solid tumors would be an 
invaluable aid. 
 
2. METHODS 
2.1 Gold nanoshell 
 
Gold nanoshells are a new type of optically tunable particle composed of a dielectric core (silica, ~125nm in 
diameter in our case) coated with an ultra-thin gold shell (10-12 nm in our case). The optical properties of nanoshells 
depend dramatically on the relative sizes of the core and the thickness of the gold shell. By varying the relative core size 
and shell thicknesses, the optical properties of nanoshells can be varied across a broad range of the electromagnetic 
spectrum that spans the visible and the infrared regions. Nanoshells can be made either to preferentially absorb or scatter 
light by varying the absolute size of the particle relative to the wavelength of the light at their optical resonance. In our 
cancer applications, gold nanoshells designed to absorb near-infrared wavelengths are used. The peak optical absorption 
of nanoshells is at ~800 nm (see figure 16), a wavelength that exhibits optimal penetration into scattering biological 
tissues and is the isosbestic point of molar extinction spectra of oxy- and deoxy-hemoglobin, thus reducing the effect of 
blood oxygenation changes on photoacoustic signals. In addition, the gold nanoshells we used here is PEGylated 
nanoshells. PEGylation prolongs the circulation time. The PEGylated nanoshells were measured to have a half-life of 
~3.7 h in the blood of immune-competent BALB/c mice.  
 
2.2 System setup 
 
Figure 2 shows the experimental setup of photoacoustic microscopy for in vivo imaging of nanoshell 
extravasation in solid tumors. A tunable Ti:Sapphire laser (LT-2211A, Lotis) and a tunable dye laser (ND6000, 
Continuum) were employed to provide pulses with wavelengths of 800 nm and 584 nm, respectively. Pre-scans prior to 
nanoshell injection were taken using a 584-nm laser source to highlight blood content and an 800-nm laser source to 
mark the background limit for nanoshell accumulation and to monitor the nanoshell accumulation. The laser pulse 
widths for the Ti:Sapphire and the dye laser were 15 ns and 6.5 ns, respectively, and the pulse repetition rate was 10 Hz 
for both lasers. The laser output was delivered to a multimode fiber with a 0.6 mm diameter. The tip of the fiber was 
positioned so as to have a diverging annular beam, focused using a conical lens so that the light focus overlapped with 
the focus of the high-frequency ultrasound transducer (V214-BC-RM, Panametrics). The incident light energy densities 
of both the NIR and visible light sources on the sample surface were controlled to be less than 3 and 1 mJ/cm2, 
respectively, which are well within the safety standards. An ultrasound transducer with a central frequency of 50 MHz, a 
nominal bandwidth of 70%, and a numerical aperture (NA) of 0.44 was used, which proves a lateral resolution of 45 µm 
and an axial resolution of 15 µm. The photoacoustic signals received by the transducer were amplified and then 
recorded by a digital oscilloscope (TDS 5034B, Tektronics). The transducer was immersed in water inside a plastic 
container with an opening at the bottom that was sealed with a thin transparent disposable membrane. The animal was 
placed outside the container below the membrane, and the ultrasonic coupling was further secured by coupling gel. A 
mechanical stage provided lateral scanning of the photoacoustic transducer, which allowed a cross-sectional B-scan and 
a planar C-scan over the sample to be obtained. 
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Figure 1. Extinction spectrum of the nanoshell solution, where the absorption peak is about 800 nm6. 
 
 
 
2.3 Animal handling 
 
Immunocompetent BALB/c mice weighing about 20 grams were used for the in vivo animal experiments. The 
mice were inoculated with CT26.wt murine colon carcinoma cells subcutaneously in the upper lumbar area to the left of 
the vertebra 7 days before the experiment. Imaging was performed under isoflurane gas anesthesia with a dose of 1% 
pure oxygen at a 1 L/min flow rate. The body temperature of the animal was maintained by controlling the temperature 
of the water in the immersion container to 39 oC7. The pulse rate and the global arterial blood oxygenation were 
monitored during the entire experiment using a pulse oximeter (Model 8600, Nonin Medical Inc.)  Pre-scans prior to 
nanoshell injection were taken using a 584-nm laser source to highlight blood content and an 800-nm laser source to 
mark the background limit for nanoshell accumulation. PEGylated nanoshells with a peak optical absorption at ~800 nm 
were then intravenously administered. The nanoshell dose is about 3x109 NS/g BW (~ 4x1010 NS/mL blood). After 
injection, the three-dimensional nanoshell distribution inside the tumor was monitored by PAM for 7 hours. After 
imaging, the mice were sacrificed using pentobarbital (120 mg/kg, IP). All of the experimental animal procedures were 
approved by the University Laboratory Animal Care Committee of Texas A&M University. 
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Figure 2. Schematic of the photoacoustic microscope for in vivo imaging of nanoshell extravsation in solid tumors 
 
 
3. RESULTS AND DISCUSSION 
 
PAM measurements illustrate the passive uptake of nanoshells within the cortex of an inoculated CT26.wt 
tumor.  Figures 3 (a) and (b) are, respectively, C-scan images taken prior to nanoshell injection using a 584 nm laser 
source to highlight blood content and an 800 nm laser source to set the background limit for nanoshell accumulation. In 
C-scan images, the maximum amplitude of each scan line along the depth direction versus the 2D transducer position is 
plotted. Figure 3(a) shows the feeding vessels and tumor angiogenesis well. The tumor position is marked by the 
character “T”. In figure 3(b), the bright spots are caused by electronic noise and the interference signals from the scalp 
surface. Note that without nanoshells, signal amplitudes in the 800 nm image is about one order smaller than those in 
the 584 nm image even though the incident light energy of 800 nm is about 3 times higher than that of 584 nm. Figures 
3(c) and (d) show PAM C-scan images taken using an 800 nm laser source at 0.5 and 3 hours post nanoshell injection, 
respectively.  Compared with figure 3(b), the nanoshells improve the signal amplitudes by about one order, as 
indicated by the colorbars in figures 3(b), (c), and (d). In addition, the blood contrast is enhanced. The nanoshell 
accumulation delineates the tumor contour. Figures 3(c) and (d) illustrate the progressive uptake of nanoshells within 
the tumor cortex, as shown at the positions indicated by the arrows in figure 3(c). Note that the position of the mouse 
was slightly shifted toward the right hand side during the administration of nanoshells, which can be observed from 
figure 3. 
 
Figures 4(a) shows the B-scan image at 584 nm before nanoshell injection, of which the scanning position 
corresponds to the dashed line in figure 3(d). In B-scan images, the vertical axis is the depth and the horizontal axis 
shows the lateral scanning position. In figure 4(a), the scalp surface is indicated by the dashed line, and the tumor 
position is marked by the character “T”. Figure 4(a) shows the positions of the vessels. Figure 4(b) is the B-scan image 
taken at 800 nm prior to nanoshell injection to set the background limit for nanoshell accumulation.  Figures 4(c) and 
(d) show PAM B-scan images taken using an 800 nm laser source at 0.5 and 3 hours post nanoshell injection, 
respectively. The bright spots, as indicated by the arrow in figures 4 (c) and (d), in these two images are the 
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photoacoustic signals from accumulated nanoshells. These two images show the depth information where nanoshells 
accumulate, which also indicate the nanoshell distributes around the tumor surface, i.e., tumor cortex. 
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Figure 3. (a) C-scan image at 584 nm before nanoshell injection to highlight initial blood content; (b) Prescan image (C-
scan) at 800 nm to set pre-nanoshell injection image baseline; (c) and (d) C-scan images of nanoshell accumulation in 
tumor cortext at 0.5 and 3 hours after nanoshell injection (at 800 nm), respectively 
 
An absence of nanoshells within the tumor core is observed in figures 3(c) and (d), and figures 4(c) and (d). It 
is shown that nanoshell accumulation is heterogeneous in tumors: more concentrated within the tumor cortex and 
largely absent from the tumor core. These results are further verified by histology. This correlates with others’ 
observation that drug delivery within tumor cores is ineffective because of both high interstitial pressure and tendency to 
necrosis of tumor cores9,10. Moreover, an absence of nanoshells on the top surface of the tumor is also observed.  
Membrane pressure may preclude accumulation there. 
 
By observing the changes in photoacoustic signals from the vessels and tumor regions, the time-dependent 
variation of absorption in the vessels and tumor regions attributable to the nanoshells can be studied. We calculated the 
averaged optical absorption in vessels and tumor regions as a function of time, which represents the clearance profiles of 
the nanoshells in vessles and tumor regions, respectively. It is shown that nanoshells in vessels are gradually cleared out 
by the circulatory system of the mouse and nanoshells in tumor regions are progressively uptaken at the tumor site 
owing to poor lymphatic drainage of the tumor (i.e., the enhanced permeability and retention effect). At ~7 hours after 
nanoshell injection, the contrast ratio of the tumor regions to vessels is about 2 to 1. 
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Figure 4. (a) B-scan image at 584 nm before nanoshell injection to highlight initial blood content; (b) Prescan image (B-
scan) at 800 nm to set pre-nanoshell injection image baseline; (c) and (d) B-scan images of nanoshell accumulation in 
tumor cortext at 0.5 and 3 hours after nanoshell injection (at 800 nm). 
 
 
5. CONCLUSIONS 
 
In summary, by employing the PAM, we successfully imaged extravasation of gold nanoshells, a novel 
nanoparticle contrast agent, from solid tumor vasculatures in vivo with high spatial resolution and satisfactory 
sensitivity. It is found that nanoshell accumulation is heterogeneous in tumors: more concentrated within the tumor 
cortex and largely absent from the tumor core. Using exogenous contrast from nanoshells, image contrast is  also 
significantly enhanced at 800 nm. Since gold nanoshells have been recently applied to photothermal therapy for 
subcutaneous tumors, we anticipate that PAM will be important to this therapeutic technique to monitor the 
accumulation of gold nanoshells. In addition, by using nanoshells conjugated to bioactive materials such as proteins, 
antibodies, and drugs, the technique presented here (PAM plus nanoshells) will potentially enable molecular imaging 
and therapeutic monitoring11.  
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